BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS
A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate. La présente...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GULBIN, TIMOTHY, CHARLES GODLEWSKI, MICHAEL, SELDEN WHITE, DANIEL, JEROME, JR MYATT, GRAHAM, JOHN |
| description | A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
La présente invention concerne une suspension pharmaceutique liquide pour administration orale contenant un agent pharmaceutique contenant du bismuth, un système de suspension, et de l'eau. Le système de suspension peut contenir d'environ 0,001 % à environ 0,2 % de gomme de gellane et d'environ 0,001 % à environ 0,75 % de silicate de magnésium et d'aluminium. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015168242A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015168242A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015168242A13</originalsourceid><addsrcrecordid>eNrjZDBx8gz2DQ3x0HX29wtx9PTz9HNX8PEMDPV0UQjwcAzydXR2DQ3xdHb0UQgODQ5w9Qv29PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoZmFkYmRo6GxsSpAgCfhSjR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS</title><source>esp@cenet</source><creator>GULBIN, TIMOTHY, CHARLES ; GODLEWSKI, MICHAEL, SELDEN ; WHITE, DANIEL, JEROME, JR ; MYATT, GRAHAM, JOHN</creator><creatorcontrib>GULBIN, TIMOTHY, CHARLES ; GODLEWSKI, MICHAEL, SELDEN ; WHITE, DANIEL, JEROME, JR ; MYATT, GRAHAM, JOHN</creatorcontrib><description>A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
La présente invention concerne une suspension pharmaceutique liquide pour administration orale contenant un agent pharmaceutique contenant du bismuth, un système de suspension, et de l'eau. Le système de suspension peut contenir d'environ 0,001 % à environ 0,2 % de gomme de gellane et d'environ 0,001 % à environ 0,75 % de silicate de magnésium et d'aluminium.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151105&DB=EPODOC&CC=WO&NR=2015168242A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151105&DB=EPODOC&CC=WO&NR=2015168242A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GULBIN, TIMOTHY, CHARLES</creatorcontrib><creatorcontrib>GODLEWSKI, MICHAEL, SELDEN</creatorcontrib><creatorcontrib>WHITE, DANIEL, JEROME, JR</creatorcontrib><creatorcontrib>MYATT, GRAHAM, JOHN</creatorcontrib><title>BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS</title><description>A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
La présente invention concerne une suspension pharmaceutique liquide pour administration orale contenant un agent pharmaceutique contenant du bismuth, un système de suspension, et de l'eau. Le système de suspension peut contenir d'environ 0,001 % à environ 0,2 % de gomme de gellane et d'environ 0,001 % à environ 0,75 % de silicate de magnésium et d'aluminium.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBx8gz2DQ3x0HX29wtx9PTz9HNX8PEMDPV0UQjwcAzydXR2DQ3xdHb0UQgODQ5w9Qv29PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoZmFkYmRo6GxsSpAgCfhSjR</recordid><startdate>20151105</startdate><enddate>20151105</enddate><creator>GULBIN, TIMOTHY, CHARLES</creator><creator>GODLEWSKI, MICHAEL, SELDEN</creator><creator>WHITE, DANIEL, JEROME, JR</creator><creator>MYATT, GRAHAM, JOHN</creator><scope>EVB</scope></search><sort><creationdate>20151105</creationdate><title>BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS</title><author>GULBIN, TIMOTHY, CHARLES ; GODLEWSKI, MICHAEL, SELDEN ; WHITE, DANIEL, JEROME, JR ; MYATT, GRAHAM, JOHN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015168242A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GULBIN, TIMOTHY, CHARLES</creatorcontrib><creatorcontrib>GODLEWSKI, MICHAEL, SELDEN</creatorcontrib><creatorcontrib>WHITE, DANIEL, JEROME, JR</creatorcontrib><creatorcontrib>MYATT, GRAHAM, JOHN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GULBIN, TIMOTHY, CHARLES</au><au>GODLEWSKI, MICHAEL, SELDEN</au><au>WHITE, DANIEL, JEROME, JR</au><au>MYATT, GRAHAM, JOHN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS</title><date>2015-11-05</date><risdate>2015</risdate><abstract>A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
La présente invention concerne une suspension pharmaceutique liquide pour administration orale contenant un agent pharmaceutique contenant du bismuth, un système de suspension, et de l'eau. Le système de suspension peut contenir d'environ 0,001 % à environ 0,2 % de gomme de gellane et d'environ 0,001 % à environ 0,75 % de silicate de magnésium et d'aluminium.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2015168242A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | BISMUTH-CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A52%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GULBIN,%20TIMOTHY,%20CHARLES&rft.date=2015-11-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015168242A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |